Skip to main content
Caplight Logo









DirectSens GmbH

DirectSens GmbH

Private
ViennaHealthcare & Life Scienceshttps://www.directsens.com/

Last Round

Grant

Jun 24, 2024

Total Funding Raised

$500,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

DirectSens GmbH is a biotechnology company that develops and manufactures enzyme-based biosensors for healthcare diagnostics and food safety applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Sensors, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

biosensorsenzyme engineeringbiotech manufacturinganalytical reagentsfood safety testingclinical diagnosticscontract manufacturingpoint of care testingPOCTmetabolite measurementlab on a chiprapid testingbiotech R&Dquality control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DirectSens GmbH Comparables

Compare DirectSens GmbH with similar companies based on industry and business-model similarity.

DirectSens GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biolan Microbiosensores
82%
Biosentec
81%
Zimmer & Peacock
81%

DirectSens GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 24, 2024
VC RoundDec 23, 2016

Key People

Founding team and executive leadership

Christoph Sygmund

CEO

Executive Team

Roman Kittl

COO

Executive Team

DirectSens GmbH Investors

Notable investors and investment history

DirectSens GmbH investors
InvestorRounds
Austria WirtschaftsservicePre Seed, Seed
FFG Austrian Research Promotion AgencyAngel, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 40% MoM.

  • May 11, 2026

    Monthly visitors increased 31% MoM.

Recent news

Latest coverage and updates

  • launchesSep 23, 2026

    DirectSens GmbH partners to launch MetMark(TM) AHB Test in the United States

DirectSens GmbH Filings

Explore SEC and related filing metadata, where available.

DirectSens GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DirectSens GmbH's valuation, stock price, and market status.

Is DirectSens GmbH a public or private company?

DirectSens GmbH is a private company.

What is the current stock price of DirectSens GmbH?

DirectSens GmbH is a private company, so its shares have no public market price. Caplight tracks DirectSens GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is DirectSens GmbH worth (valuation)?

Valuation information for DirectSens GmbH is not publicly available.

Can I buy DirectSens GmbH stock?

DirectSens GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was DirectSens GmbH's last funding round?

DirectSens GmbH's most recent funding round was Grant on June 24, 2024.

Who are the main investors in DirectSens GmbH?

Key investors in DirectSens GmbH include Austria Wirtschaftsservice, FFG Austrian Research Promotion Agency.

Will DirectSens GmbH IPO soon?

No public IPO plans have been announced for DirectSens GmbH.

How can I track DirectSens GmbH secondary market activity?

Caplight tracks bids, offers, and trades in DirectSens GmbH's shares on secondary markets.

Firmographic Details

HeadquartersVienna
Employee Range15
Year Founded2013
Last FundingJun 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?